Works from 2026
A Quality Improvement Evaluation of Sickle Cell Pain Crisis Management in Community Hospitals: Assessing Length of Stay Data Across Inpatient Provider Groups, Stephen Smetana DO, Insia Rizvi MD, Magdalena Flejsierowicz MD, Dawn Wankowski MS, and James O. Adefisoye PhD (Poster)
Missed Opportunities: Sex Disparities in DEXA Screening Among Cancer Patients Receiving Hormonal Therapy, Faiz Hussain MD, Pooja Bhatt MD, Logan Daines DO, Magdalena Flejsierowicz MD, Dawn Wankowski MS, and James O. Adefisoye PhD (Poster)
Pertuzumab and trastuzumab in patients with ERBB2/3-altered urothelial or ovary/fallopian tube cancer: Results from the targeted agent and profiling utilization registry study, John K. Chan, Michael Rothe, Elizabeth Garrett-Mayer, et al. (Article)
The enigma of sickle cell hepatopathy: Pathophysiology, clinical manifestations and therapy, Insia Rizvi, Divya Solipuram, Navneet Kaur, et al. (Article)
Works from 2025
Educational impact of a podcast curriculum for hematology/oncology fellows: Final results of the multicenter cluster randomized PODCAST-HOF trial, Vivek G. Patel, Karine Tawagi, Samantha A. Armstrong, et al. (Article)
Immune Checkpoint Inhibitor Complications in Triple Negative Breast Cancer: Evaluating Oncologist Monitoring and Management of Adrenal Insufficiency and Hypophysitis, Stephen Smetana DO, Daniel Mundt MD, Magdalena Flejsierowicz MD, and James Adefisoye PhD (Abstract)
Palbociclib in patients (pts) with ovarian cancer (OC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, Dan Steven Veljovich, Michael Rothe, Pam K. Mangat, et al. (Abstract)
Pertuzumab plus trastuzumab (P+T) in patients (pts) with bladder (BC) and ovarian cancer (OC) with ERBB2/3 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, John K. Chan, Michael Rothe, Pam K. Mangat, et al. (Abstract)
Immune Checkpoint Inhibitor Complications in Triple Negative Breast Cancer: Evaluating Oncologist Monitoring and Management of Adrenal Insufficiency and Hypophysitis, Stephen Smetana DO, Daniel Mundt MD, Magdalena Flejsierowicz MD, and James Adefisoye PhD (Oral/Podium Presentation)
Works from 2024
A multicenter analysis evaluating educational resources utilized by hematology/oncology fellows (HOF), Ronak Mistry, Inas Abuali, Ankoor Biswas, et al. (Abstract)
Utility of a collaborative hematology oncology (HO) podcast series for post-ASCO updates and teaching critical appraisal, Megan Connor, Samantha Ann Armstrong, Ankoor Biswas, et al. (Abstract)
Somatic POLE mutation and ultra-hypermutated genotype in a de novo high-grade, isocitrate dehydrogenase wild-type glioma: Treatment implications, Daniel Mundt, Isaac Melguizo-Gavilanes, Anil Y. Tumu, et al. (Article)
Works from 2022
18-year-old presenting with non-specifical abdominal/back pain diagnosed with metastatic EBV nasopharyngeal carcinoma, Kazi Khan, Abdul Aziz Siddiqui, and Ankoor Biswas (Poster)
Hyperglycemia-Induced osmotic demyelination syndrome in a type 2 diabetic with stable serum sodium, Jesse Galuk, Ian Kuckelman, and Ankoor Biswas (Poster)